(DBX7) Xtrackers - Nifty 50 Swap - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0292109690 • India Equity
DBX7: Indian, Equity, Index, Tracker, Fund
‣ Company URL: http://www.dws.lu ‣ Domicile: Luxembourg ‣ Index Name: Morningstar India TME NR USD
Additional Sources for DBX7 ETF
DBX7 ETF Overview
| Market Cap in USD | 205m |
| Category | India Equity |
| TER | 1.48% |
| IPO / Inception | 2007-07-05 |
DBX7 ETF Ratings
| Growth 5y | 70.4% |
| Fundamental | - |
| Dividend | - |
| Rel. Strength Industry | -17.2 |
| Analysts | - |
| Fair Price Momentum | 233.73 EUR |
| Fair Price DCF | - |
DBX7 Dividends
No Dividends PaidDBX7 Growth Ratios
| Growth Correlation 3m | -40.9% |
| Growth Correlation 12m | 69.5% |
| Growth Correlation 5y | 93.3% |
| CAGR 5y | 10.90% |
| CAGR/Mean DD 5y | 1.61 |
| Sharpe Ratio 12m | 0.10 |
| Alpha | -10.10 |
| Beta | 0.53 |
| Volatility | 16.36% |
| Current Volume | 1.3k |
| Average Volume 20d | 1.9k |
What is the price of DBX7 stocks?
As of January 30, 2025, the stock is trading at EUR 245.60 with a total of 1,275 shares traded.
Over the past week, the price has changed by -0.12%, over one month by -2.98%, over three months by -5.21% and over the past year by +5.18%.
As of January 30, 2025, the stock is trading at EUR 245.60 with a total of 1,275 shares traded.
Over the past week, the price has changed by -0.12%, over one month by -2.98%, over three months by -5.21% and over the past year by +5.18%.
Is Xtrackers - Nifty 50 Swap a good stock to buy?
Yes. Based on ValueRay Analyses, Xtrackers - Nifty 50 Swap (XETRA:DBX7) is currently (January 2025) a good stock to buy. It has a ValueRay Growth Rating of 70.37 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DBX7 as of January 2025 is 233.73. This means that DBX7 is currently overvalued and has a potential downside of -4.83%.
Yes. Based on ValueRay Analyses, Xtrackers - Nifty 50 Swap (XETRA:DBX7) is currently (January 2025) a good stock to buy. It has a ValueRay Growth Rating of 70.37 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DBX7 as of January 2025 is 233.73. This means that DBX7 is currently overvalued and has a potential downside of -4.83%.
Is DBX7 a buy, sell or hold?
Xtrackers - Nifty 50 Swap has no consensus analysts rating.
Xtrackers - Nifty 50 Swap has no consensus analysts rating.
What are the forecast for DBX7 stock price target?
According to ValueRays Forecast Model, DBX7 Xtrackers - Nifty 50 Swap will be worth about 255.9 in January 2026. The stock is currently trading at 245.60. This means that the stock has a potential upside of +4.18%.
According to ValueRays Forecast Model, DBX7 Xtrackers - Nifty 50 Swap will be worth about 255.9 in January 2026. The stock is currently trading at 245.60. This means that the stock has a potential upside of +4.18%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 255.9 | 4.2% |